Evoke Pharma
EVOK
EVOK was delisted on the 16th of December, 2025.
21 hedge funds and large institutions have $5.07M invested in Evoke Pharma in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
1.17% more ownership
Funds ownership: 11.7% → 12.87% (+1.2%)
9% less funds holding
Funds holding: 23 → 21 (-2)
9% less capital invested
Capital invested by funds: $5.58M → $5.07M (-$510K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
+$287K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$182K |
| 3 |
BlackRock
New York
|
+$50.9K |
| 4 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$41.4K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$11.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$49K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$31K |
| 3 |
Bank of New York Mellon
New York
|
-$13.8K |
| 4 |
Morgan Stanley
New York
|
-$13K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.45K |
EVOK Hedge Fund Activity: Q2 2017 in Review
21 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Evoke Pharma (EVOK) for Q2 2017, worth a combined $5.07M — down 9.1% from $5.58M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of EVOK and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was State of Michigan Retirement System, adding an estimated $287K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $49K sold.
- 21 institutional investors held Evoke Pharma (EVOK) as of Q2 2017, down from 23 in Q1 2017.
- Funds reported $5.07M of Evoke Pharma stock for Q2 2017, down 9.1% quarter-over-quarter.
- 1 fund opened new Evoke Pharma positions in Q2 2017 and 3 closed out, a net change of -2 holders.
- The largest Evoke Pharma buyer in Q2 2017 was State of Michigan Retirement System, an estimated $287K added.
- The largest Evoke Pharma seller in Q2 2017 was Virtu KCG Holdings, an estimated $49K sold.
Based on aggregated 13F filings for Q2 2017.